Answers are grounded in this paper and cite their sources.
Recent studies reveal that ascomycete fungi establish an endosymbiotic association with marine algae [1-4]. Akin to the endophytes of terrestrial plants in causing disease-free infections in their hosts, these fungi need to be studied with the same zeal as endophytes as they are a promising source of novel bioactive metabolites. The Fungal Endosymbionts of Macroalage (FEM) elaborate molecules exhibiting antitumour, antioxidant, anticancer, antimicrobial, antifungal, cytotoxic and other bioactivities [5-7]. An Aspergillus sp. harboured by a marine alga elaborates antibiotics effective against methicillin resistant bacteria [8]; FEM isolated from macroalgae of North Atlantic produce antibacterial and larvicidal metabolites [7]. A Fusarium endosymbiont of a marine alga off the coast of southern India formed antimalarial metabolites showing activity against blood stage Plasmodium falciparum [9]. The synthetic ability of FEM is further substantiated by Flewelling et al. [10] who showed that a Penicillium endosymbiont of Fucus spiralis produced epiepoformin, phlyllostine, patulin and cladosporin-a metabolite that has not been previously reported as a product of this genus. Although these few studies identify FEM as a promising source of novel metabolites of pharmaceutical and agricultural importance, a number of challenges confront us before their potential could be fully realized. We identify some roadblocks which need to be addressed.
No takes yet. Share an insight, caveat, or question.
Johnson JA Suryanarayanan TS (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: